Combination of IL-12 gene therapy and CTX chemotherapy inhibits growth of primary B16(F10) melanoma tumors in mice

Acta Biochimica Polonica

Volumn 53, Issue 2, 2006, Pages 357-360

  Mitrus, Iwona ^a   Delić, Klaudia ^a   Wróbel, Natalia ^a   Missol Kolka, Ewa ^a   Szala, Stanisław ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Antiangiogenic therapy; Combined therapy; Interleukin 12 gene

Indexed keywords

ANIMALIA; MURINAE;

EID: 33745846430     PISSN: 0001527X     EISSN: 1734154X     Source Type: Journal    
DOI: 10.18388/abp.2006_3349     Document Type: Article

References (11)

1. Browder T, Butterfield CE, Kraling BM, Shi B, Marshall B, O'Reilly MS, Folkman J (2000) Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res 60: 1878-1886.
2. Budryk M, Wilczynska U, Szary J, Szala S (2000) Direct transfer of IL-12 gene into growing Renca tumors. Acta Biochim Polon 47: 385-391.
3. Carpentier AF, Auf G, Delattre JY (2003) CpG-oligonucleotides for cancer immunotherapy: review of the literature and potential applications in malignant glioma. Front Biosci 8: e115-127.
4. Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-1186.
5. Hendrzak JA, Brunda MJ (1995) Interleukin-12. Biologic activity, therapeutic utility, and role in disease. Lab Invest 72: 619-637.
6. Indraccolo S (2004) Undermining tumor angiogenesis by gene therapy: an emerging field. Curr Gene Ther 4: 297-308.
7. Kerbel RS, Kamen BA (2004) The anti-angiogenic basis of metronomic chemotherapy. Nat Rev Cancer 4: 423-436.
8. Longo R, Sarmiento R, Fanelli M, Capaccetti B, Gattuso D, Gasparini G (2002) Anti-angiogenic therapy: rationale, challenges and clinical studies. Angiogenesis 5: 237-256.
9. Shi F, Rakhmilevich AL, Heise CP, Oshikawa K, Sondel PM, Yang NS, Mahvi DM (2002) Intratumoral injection of interleukin-12 plasmid DNA, either naked or in complex with cationic lipid, results in similar tumor regression in a murine model. Mol Cancer Ther 1: 949-957.
10. Sivridis E, Giatromanolaki A, Koukourakis MI (2003) The vascular network of tumours - what is it not for? J Pathol 201: 173-180.
11. Tandle A, Blazer DG 3rd, Libutti SK (2004) Antiangiogenic gene therapy of cancer: recent developments. J Transl Med 2: 22-41.